3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
29
Myelodysplastic Syndromes
10
Advanced Solid Tumors
8
Leukemia, Myelomonocytic, Chronic
6
Myeloproliferative Disorders
5
Advanced Solid Tumor
5
Ovarian Neoplasms
4
Neoplasms
4
Multiple Myeloma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Small Cell Lung Carcinoma
3
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Monocytic, Acute
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumor
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Biphenotypic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Interventions
pembrolizumab
52
Paclitaxel
19
Cisplatin
14
Carboplatin
14
lenvatinib
10
Docetaxel
8
Saline Solution
7
Capecitabine
7
Pemetrexed
6
Oxaliplatin
6
Gemcitabine
6
Fluorouracil
6
Leucovorin
5
Albumin-Bound Paclitaxel
5
olaparib
4
belzutifan
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
patritumab deruxtecan
3
Glucose
3
Acetaminophen
3
liposomal doxorubicin
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Injections
×
90 days
×
Clear all
No trials found.